Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MLYS Mineralys Therapeutics, Inc.

休市中 12-20 16:00:00 EST

12.34

+0.51

+4.31%

盘后12.34

+0.000.00%

16:13 EST

最高12.50	最低11.55	成交量51.27万
今开11.73	昨收11.83	日振幅8.03%
总市值6.14亿	流通市值3.34亿	总股本4,977万
成交额621.68万	换手率1.89%	流通股本2,705万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":12.34,"timestamp":1734728400000,"preClose":11.83,"halted":0,"volume":512659,"hourTrading":{"tag":"盘后","latestPrice":12.34,"preClose":12.34,"latestTime":"16:13 EST","volume":81263,"amount":1002785.5385,"timestamp":1734729212363},"delay":0,"floatShares":27053412,"shares":49768669,"eps":-3.325675,"marketStatus":"休市中","marketStatusCode":7,"change":0.51,"latestTime":"12-20 16:00:00 EST","open":11.73,"high":12.5,"low":11.55,"amount":6216849.591484,"amplitude":0.080304,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.325675,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1676005200000,"adjPreClose":11.83,"preHourTrading":{"tag":"盘前","latestPrice":11.96,"preClose":11.83,"latestTime":"08:15 EST","volume":1,"amount":11.96,"timestamp":1734700502110},"postHourTrading":{"tag":"盘后","latestPrice":12.34,"preClose":12.34,"latestTime":"16:13 EST","volume":81263,"amount":1002785.5385,"timestamp":1734729212363},"volumeRatio":4.961261,"impliedVol":0.3315,"impliedVolPercentile":0.2302},"requestUrl":"/m/hq/s/MLYS/tweets","defaultTab":"tweets","newsList":[{"id":"2492440940","title":"Mineralys Therapeutics, Inc.盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440940?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:30","pubTimestamp":1734708631,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时30分，Mineralys Therapeutics, Inc.股票出现波动，股价大幅上涨5.58%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings, Inc涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2213.78%、107.60%、66.36%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings, Inc、Psyence Biomedical Ltd.，振幅分别为84.80%、67.11%、50.00%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220233032984cfd98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220233032984cfd98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2492592291","title":"Mineralys Therapeutics, Inc.盘中异动 快速跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492592291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492592291?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:31","pubTimestamp":1734553907,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时31分，Mineralys Therapeutics, Inc.股票出现波动，股价急速下挫5.18%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.41%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3221.50%、675.72%、350.58%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、142.23%、105.17%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043148a1f955bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043148a1f955bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MLYS"],"gpt_icon":0},{"id":"2491358385","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.02%报12.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491358385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491358385?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:15","pubTimestamp":1734027345,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时15分，Mineralys Therapeutics, Inc.股票出现波动，股价大幅跳水5.02%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3892.78%、1025.29%、89.21%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、88.91%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213021546a1e9b4e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213021546a1e9b4e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2490043721","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.10%报12.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490043721?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:39","pubTimestamp":1733848757,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时39分，Mineralys Therapeutics, Inc.股票出现异动，股价急速跳水5.10%。截至发稿，该股报12.65美元/股，成交量5.7186万股，换手率0.11%，振幅4.20%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211003917984b128b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211003917984b128b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2489023404","title":"Mineralys Therapeutics, Inc.盘中异动 早盘快速上涨5.40%报12.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489023404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489023404?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:26","pubTimestamp":1733498767,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时26分，Mineralys Therapeutics, Inc.股票出现波动，股价急速拉升5.40%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Adc Therapeutics Sa、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Cervomed Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.72%、40.22%、27.84%，振幅较大的相关个股有Adc Therapeutics Sa、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为33.33%、27.68%、26.58%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232607a1d98c61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232607a1d98c61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2488289619","title":"Mineralys Therapeutics, Inc.盘中异动 临近午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488289619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488289619?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:36","pubTimestamp":1733243812,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时36分，Mineralys Therapeutics, Inc.股票出现波动，股价快速下跌5.19%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Janux Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为144.89%、122.98%、117.39%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为69.23%、59.76%、51.13%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120400365398e52154&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120400365398e52154&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2488702236","title":"Mineralys Therapeutics, Inc.盘中异动 早盘股价大涨5.72%报13.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488702236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488702236?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:49","pubTimestamp":1733150988,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时49分，Mineralys Therapeutics, Inc.股票出现异动，股价快速上涨5.72%。截至发稿，该股报13.50美元/股，成交量2.1085万股，换手率0.04%，振幅6.85%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224949a266a365&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224949a266a365&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2486031619","title":"Mineralys Therapeutics, Inc.盘中异动 快速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486031619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486031619?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:53","pubTimestamp":1732550018,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时53分，Mineralys Therapeutics, Inc.股票出现异动，股价快速拉升5.20%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Alpha Tau Medical Ltd C/Wts 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为112.63%、101.65%、66.94%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.，振幅分别为91.09%、78.65%、75.84%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125235338abde226d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125235338abde226d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2485297632","title":"Mineralys Therapeutics, Inc.盘中异动 急速拉升5.14%报12.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485297632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485297632?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:12","pubTimestamp":1732299161,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时12分，Mineralys Therapeutics, Inc.股票出现波动，股价大幅拉升5.14%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、Candel Therapeutics, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1875.73%、153.85%、95.97%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为82.83%、77.41%、72.75%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112302124198e44371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112302124198e44371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MLYS"],"gpt_icon":0},{"id":"2485703415","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.08%报11.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485703415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485703415?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:40","pubTimestamp":1732203622,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时40分，Mineralys Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为447.08%、87.89%、77.27%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为141.46%、76.33%、74.25%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123402298e43f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123402298e43f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MLYS"],"gpt_icon":0},{"id":"2484974223","title":"Mineralys Therapeutics, Inc.盘中异动 快速上涨5.00%报11.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484974223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484974223?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:12","pubTimestamp":1732043568,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时12分，Mineralys Therapeutics, Inc.股票出现波动，股价大幅上涨5.00%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1191.60%、839.14%、148.67%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.，振幅分别为91.10%、81.67%、68.54%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120031248a2466b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120031248a2466b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MLYS","BK4139"],"gpt_icon":0},{"id":"2483859522","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483859522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483859522?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:09","pubTimestamp":1731524995,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时09分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅下跌5.23%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为545.96%、458.98%、152.96%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为131.00%、86.83%、73.71%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403095598e4270c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403095598e4270c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2482714528","title":"Mineralys Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482714528","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482714528?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:43","pubTimestamp":1731382996,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Mineralys Therapeutics Inc MLYS.OQ报告，截至9月30日的季度调整后每股亏损1.13美元，低于去年同期的每股收益-57美分。七位分析师对该季度的平均预期是每股亏损 83 美分。Mineralys Therapeutics Inc 报告的季度每股收益为亏损 1.13 美元。该公司当季亏损 5634 万美元。Mineralys Therapeutics Inc的股价本季度上涨了15.9%，今年迄今为止上涨了63.3%。华尔街对 Mineralys Therapeutics Inc 的 12 个月目标价中位数为 31.00 本摘要由 LSEG 数据于 11 月 12 日 03:42 a.m. UTC 机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ0AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2482376377","title":"Mineralys Therapeutics, Inc.盘中异动 股价大涨5.06%报14.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482376377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482376377?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:42","pubTimestamp":1731343379,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时42分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅拉升5.06%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为652.27%、484.16%、195.36%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为123.43%、72.42%、61.39%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200425998e41da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200425998e41da0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2482615384","title":"Mineralys Therapeutics Inc 预计每股亏损83美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482615384","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482615384?lang=zh_cn&edition=full","pubTime":"2024-11-09 08:37","pubTimestamp":1731112663,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc 预计每股亏损83美分 - 财报前瞻Mineralys Therapeutics Inc MLYS.OQ MLYS.O将于11月11日公布截至2024年9月30日的财报，预计季度营收将保持不变。LSEG分析师对Mineralys Therapeutics Inc的平均预期是每股亏损83美分。华尔街对 Mineralys Therapeutics Inc 的 12 个月目标价中位数为 31.00 美元，高于其最新收盘价 14.04 美元。11月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241109:nL4T3MG01P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS"],"gpt_icon":0},{"id":"2481182117","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.02%报14.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481182117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481182117?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:20","pubTimestamp":1730992843,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时20分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为642.64%、128.04%、91.74%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc.、Ensysce Biosciences, Inc.，振幅分别为68.89%、59.31%、57.79%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2481663985","title":"Mineralys Therapeutics, Inc.盘中异动 急速上涨5.18%报14.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481663985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481663985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903555,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Mineralys Therapeutics, Inc.股票出现异动，股价快速上涨5.18%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、100.21%、52.15%，振幅较大的相关个股有Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为107.84%、106.06%、106.04%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223236aba6b0b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223236aba6b0b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2479784033","title":"Mineralys Therapeutics, Inc.盘中异动 早盘股价大跌5.15%报13.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479784033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479784033?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:50","pubTimestamp":1730382603,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时50分，Mineralys Therapeutics, Inc.股票出现异动，股价急速下跌5.15%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.42%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Aerovate Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为210.80%、200.86%、153.04%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为39.30%、28.17%、21.98%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215003ab8ba4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215003ab8ba4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2473999578","title":"Mineralys Therapeutics, Inc.盘中异动 下午盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473999578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473999578?lang=zh_cn&edition=full","pubTime":"2024-10-05 02:56","pubTimestamp":1728068211,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日02时56分，Mineralys Therapeutics, Inc.股票出现波动，股价快速上涨5.42%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Entero Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为17546.89%、94.36%、78.40%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为103.24%、69.59%、58.64%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050256519719e6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050256519719e6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2468501365","title":"Mineralys Therapeutics, Inc.盘中异动 快速拉升5.13%报12.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468501365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468501365?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:29","pubTimestamp":1726759799,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时29分，Mineralys Therapeutics, Inc.股票出现异动，股价急速上涨5.13%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4229.50%、796.71%、183.49%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为99.34%、78.69%、52.97%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232959a1db3637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232959a1db3637&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MLYS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mineralystx.com","stockEarnings":[{"period":"1week","weight":0.037},{"period":"1month","weight":-0.0206},{"period":"3month","weight":0.0538},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.6519},{"period":"ytd","weight":0.4349}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mineralys Therapeutics, Inc.最初成立于2019年5月31日，是特拉华州的一家公司。该公司是一家临床阶段生物制药公司，专注于开发药物，以治疗由异常升高的醛固酮引起的疾病。该公司的候选产品氯隆前列素是一种专有的口服高选择性醛固酮合酶抑制剂（ASI），该公司最初开发用于治疗未控制的高血压（uHTN）患者，定义为尽管服用了两种或多种抗高血压药物或抵抗性高血压（rHTN），但血压仍不能达到130/80mmHg以下的个体。在美国，有超过1.15亿患者患有持续性高血压（BP）或高血压，超过一半的患者未能实现血压目标，即目前可用的药物血压为130/80 mmHg。超过3000万接受治疗的患者没有达到血压目标，其中约2000万患者的收缩压水平超过140 mmHg。尽管服用了两种或两种以上药物，但高血压患者仍持续存在，心血管疾病或中风导致的死亡率风险分别为1.8倍和2.5倍。在一项评估200名uHTN和rHTN（目标HTN）受试者的第2阶段临床试验中，洛龙前列素显示，每天给药一次，血压下降具有临床意义和统计学意义，且耐受性良好。除高血压外，该公司还打算开发用于治疗慢性肾脏病（CKD）的氯前列素。","exchange":"NASDAQ","name":"Mineralys Therapeutics, Inc.","nameEN":"Mineralys Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mineralys Therapeutics, Inc.(MLYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mineralys Therapeutics, Inc.,MLYS,Mineralys Therapeutics, Inc.股票,Mineralys Therapeutics, Inc.股票老虎,Mineralys Therapeutics, Inc.股票老虎国际,Mineralys Therapeutics, Inc.行情,Mineralys Therapeutics, Inc.股票行情,Mineralys Therapeutics, Inc.股价,Mineralys Therapeutics, Inc.股市,Mineralys Therapeutics, Inc.股票价格,Mineralys Therapeutics, Inc.股票交易,Mineralys Therapeutics, Inc.股票购买,Mineralys Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mineralys Therapeutics, Inc.(MLYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}